Moderna Inc

NASDAQ:MRNA  
136.26
-7.12 (-4.97%)
Products

Moderna Completed EUA Submissions To U.S. FDA To Use Co's Covid Vaccine As Primary Series In Adolescents Aged 12-17 Years On May 9-CNBC Reporter Tweet

Published: 05/11/2022 18:52 GMT
Moderna Inc (MRNA) - Moderna Completed Eua Submissions to U.S. FDA to Use Co's Covid Vaccine As Primary Series in Adolescents Aged 12-17 Years on May 9-cnbc Reporter Tweet.
Moderna Completed Eua Submissions for Use of Covid Vaccine As Primary Series in Children Aged 6-11 Years,6 Years-6 Months on May 9-cnbc Reporter Tweet.
Further Company Coverage: Mrnao ((reuters.
Briefs@thomsonreuters.
Com;;)).